Neurocentria Announces Dr. Thomas Südhof to Join the Scientific Advisory Board WALNUT CREEK, Calif., Jan. 13, 2023 (GLOBE NEWSWIRE) -- Neurocentria, Inc., a privately held late-stage biotechnology company developing novel therapies for neurodegenerative and neuropsychiatric...